Editorial reviews: Introduce present-day investigation and touch upon important advances and developments in the sphere. Conclusions: Golimumab would not feel ready to maintain very long-expression remission in UC in actual life. The safety profile was very good. External citations are calculated by subtracting the volume of self-citations from the overall https://www.directivepublications.org/journal-of-digestive-and-liver-diseases/